Cargando…

Identification of novel autoantibodies based on the protein chip encoded by cancer-driving genes in detection of esophageal squamous cell carcinoma

The purpose of this study was to identify novel autoantibodies against tumor-associated antigens (TAAbs) and explore the optimal diagnosis model based on the protein chip for detecting esophageal squamous cell carcinoma (ESCC). The human protein chip based on cancer-driving genes was customized to d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Guiying, Ye, Hua, Wang, Xiao, Cheng, Lin, Ren, Pengfei, Shi, Jianxiang, Dai, Liping, Wang, Peng, Zhang, Jianying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781740/ https://www.ncbi.nlm.nih.gov/pubmed/33457096 http://dx.doi.org/10.1080/2162402X.2020.1814515

Ejemplares similares

Identification and Evaluation of Autoantibody to a Novel Tumor-Associated Antigen GNA11 as a Biomarker in Esophageal Squamous Cell Carcinoma
por: Wang, Huimin, et al.
Publicado: (2021)

Identification of Novel Autoantibodies Based on the Human Proteomic Chips and Evaluation of Their Performance in the Detection of Gastric Cancer
por: Cui, Chi, et al.
Publicado: (2021)

Autoantibodies against tumor‐associated antigens combined with microRNAs in detecting esophageal squamous cell carcinoma
por: Sun, Guiying, et al.
Publicado: (2019)

Identification of novel autoantibody signatures and evaluation of a panel of autoantibodies in breast cancer
por: Qiu, Cuipeng, et al.
Publicado: (2021)

Serum anti-SPP1 autoantibody as a potential novel biomarker in detection of esophageal squamous cell carcinoma
por: Wang, Chen, et al.
Publicado: (2022)

Serological Biomarkers for Early Detection of Hepatocellular Carcinoma: A Focus on Autoantibodies against Tumor-Associated Antigens Encoded by Cancer Driver Genes
por: Wang, Keyan, et al.
Publicado: (2020)

Anti-CXCL8 Autoantibody: A Potential Diagnostic Biomarker for Esophageal Squamous Cell Carcinoma
por: Chen, Huili, et al.
Publicado: (2022)

Serum Anti-PDLIM1 Autoantibody as Diagnostic Marker in Ovarian Cancer
por: Qiu, Cuipeng, et al.
Publicado: (2021)

Serum Autoantibodies against LRDD, STC1, and FOXA1 as Biomarkers in the Detection of Ovarian Cancer
por: Duan, Yaru, et al.
Publicado: (2022)

Using protein microarray to identify and evaluate autoantibodies to tumor‐associated antigens in ovarian cancer
por: Ma, Yan, et al.
Publicado: (2020)

Human Proteome Microarray identifies autoantibodies to tumor‐associated antigens as serological biomarkers for the diagnosis of hepatocellular carcinoma
por: Yang, Qian, et al.
Publicado: (2023)

A novel immunodiagnosis panel for hepatocellular carcinoma based on bioinformatics and the autoantibody‐antigen system
por: Wu, Jinyu, et al.
Publicado: (2021)

Anti-POSTN and Anti-TIMP1 Autoantibodies as Diagnostic Markers in Esophageal Squamous Cell Carcinoma
por: Xie, Weihong, et al.
Publicado: (2022)

Peroxiredoxin 1 is a tumor-associated antigen in esophageal squamous cell carcinoma
por: REN, PENGFEI, et al.
Publicado: (2013)

Discovering Panel of Autoantibodies for Early Detection of Lung Cancer Based on Focused Protein Array
por: Jiang, Di, et al.
Publicado: (2021)

Oncogenic enhancers drive esophageal squamous cell carcinogenesis and metastasis
por: Ye, Bo, et al.
Publicado: (2021)

Discovery and Validation of Serum Autoantibodies Against Tumor-Associated Antigens as Biomarkers in Gastric Adenocarcinoma Based on the Focused Protein Arrays
por: Yang, Qian, et al.
Publicado: (2020)

A novel autoantibody signatures for enhanced clinical diagnosis of pancreatic ductal adenocarcinoma
por: Li, Tiandong, et al.
Publicado: (2023)

Prognostic relevance of Bmi-1 expression and autoantibodies in esophageal squamous cell carcinoma
por: Liu, Wan-li, et al.
Publicado: (2010)

Autoantibodies as Potential Biomarkers for the Early Detection of Esophageal Squamous Cell Carcinoma
por: Xu, Yi-Wei, et al.
Publicado: (2014)

Autoantibodies against glucose-regulated protein 78 as serological diagnostic biomarkers in hepatocellular carcinoma
por: SHAO, QING, et al.
Publicado: (2012)

Autoantibody to MDM2: A Potential Serological Marker of Systemic Lupus Erythematosus
por: Liu, Yuan, et al.
Publicado: (2015)

Anti-CDC25B autoantibody predicts poor prognosis in patients with advanced esophageal squamous cell carcinoma
por: Dong, Jun, et al.
Publicado: (2010)

Identification of novel serum autoantibody biomarkers for early esophageal squamous cell carcinoma and high-grade intraepithelial neoplasia detection
por: Chen, Zhibin, et al.
Publicado: (2023)

The Relationship between MALAT1 Polymorphism rs3200401 C > T and the Risk of Overall Cancer: A Meta-Analysis
por: Li, Keming, et al.
Publicado: (2022)

Diagnostic Value of Autoantibodies against Ezrin in Esophageal Squamous Cell Carcinoma
por: Li, Lan, et al.
Publicado: (2017)

Identification of methylated-differentially expressed genes and pathways in esophageal squamous cell carcinoma
por: Sang, Liang, et al.
Publicado: (2020)

Using Serological Proteome Analysis to Identify and Evaluate Anti-GRP78 Autoantibody as Biomarker in the Detection of Gastric Cancer
por: Qin, Jiejie, et al.
Publicado: (2020)

Combined detection of serum Dickkopf‐1 and its autoantibodies to diagnose esophageal squamous cell carcinoma
por: Peng, Yu‐Hui, et al.
Publicado: (2016)

Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer
por: Dai, Liping, et al.
Publicado: (2017)

Serum-Derived microRNAs as Prognostic Biomarkers in Osteosarcoma: A Meta-Analysis
por: Luo, Huan, et al.
Publicado: (2020)

Suppression of Esophageal Squamous Cell Carcinoma Development by Mechanosensitive Protein Piezo1 Downregulation
por: Gao, Lu, et al.
Publicado: (2021)

Establishment and validation of an immunodiagnostic model for prediction of breast cancer
por: Qiu, Cuipeng, et al.
Publicado: (2019)

Correction to “Suppression of Esophageal Squamous Cell Carcinoma Development by Mechanosensitive Protein Piezo1 Downregulation”
por: Gao, Lu, et al.
Publicado: (2021)

Identification of novel tumor-associated antigens and evaluation of a panel of autoantibodies in detecting oral cancer
por: Xie, Weihong, et al.
Publicado: (2023)

Mini-array of multiple tumor-associated antigens (TAAs) in the immunodiagnosis of breast cancer
por: YE, HUA, et al.
Publicado: (2013)

Identification and epidemiological evaluation of gastric cancer risk factors: based on a field synopsis and meta-analysis in Chinese population
por: Duan, Fujiao, et al.
Publicado: (2021)

Serum Autoantibodies against STIP1 as a Potential Biomarker in the Diagnosis of Esophageal Squamous Cell Carcinoma
por: Xu, Yi-Wei, et al.
Publicado: (2017)

Autoantibodies: Potential clinical applications in early detection of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma
por: Xu, Yi-Wei, et al.
Publicado: (2019)

LSD1 regulates Notch and PI3K/Akt/mTOR pathways through binding the promoter regions of Notch target genes in esophageal squamous cell carcinoma
por: Hou, Guiqin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9jvpjlv070lduv4bolhae9c4sf